SAFE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SAFE is not a good buy right now for an impatient investor. The trend is still bearish (weak momentum and bearish moving averages), hedge funds are aggressively selling, and the next clear catalyst is earnings in ~2 weeks—so the risk/reward for an immediate entry is not attractive despite the stock being near support and options positioning leaning slightly bullish.
Price/Trend: SAFE is in a downtrend with bearish moving averages (SMA_200 > SMA_20 > SMA_5), indicating persistent selling pressure. Momentum: MACD histogram is negative (-0.139) and expanding lower, which typically signals downside momentum is strengthening. RSI: RSI_6 at 32.43 is near oversold territory (not a confirmed reversal signal yet). Levels: Current price 13.81 is sitting on first support S1=13.79; a clean break below 13.79 increases downside risk toward S2=13.396. Overhead resistance/pivot is 14.428, then R1=15.066. Pattern-based odds: Similar-pattern stats are slightly negative (next week -0.73%, next month -1.36%), reinforcing a cautious stance.
Intellectia Proprietary Trading Signals
Earnings catalyst: Q4 and FY2025 results scheduled after close on 2026-02-11 (calendar shows QDEC 2025 earnings after hours around 2026-02-10), which could trigger a relief rally if guidance/metrics surprise positively.
Latest reported growth (2025/Q3): Revenue +6.02% YoY, Net Income +51.48% YoY, EPS +51.85% YoY with very high gross margin (95.28%), showing operating performance was strong last quarter.
Options positioning is mildly bullish (put/call ratios < 1), suggesting some traders are leaning toward upside.
Technical downtrend remains intact: bearish MA stack and worsening MACD reduce confidence in a durable bottom today.
Hedge fund activity: “Hedge Funds are Selling,” with selling amount up 72888.36% over the last quarter—strong institutional headwind.
Analyst concerns (Morgan Stanley): muted origination activity, elevated dividend payout ratio, tenant litigation overhang, fee income headwinds, and limited visibility on unlocking value—these are fundamental overhangs that can cap upside.
Earnings risk: With IV very elevated into earnings, an impatient entry now is exposed to an event-driven gap risk without confirmation of trend reversal.
Latest quarter: 2025/Q3. Growth: Revenue increased to 96.162M (+6.02% YoY). Profitability improved sharply with Net Income 29.282M (+51.48% YoY) and EPS 0.41 (+51.85% YoY). Gross margin rose to 95.28 (+7.94% YoY). Takeaway: The most recent quarter shows strong earnings growth, but the stock is not trading like a growth winner right now (bearish trend + institutional selling), suggesting the market is focused on forward risks and visibility rather than trailing results. Politicians/Congress: No recent congress trading data available in the last 90 days.
Recent trend: Net-negative over the past month with multiple price target cuts to around $14 and a fresh downgrade.
